|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| A61K 31/16 |
| (11) | Number of the document | 2195462 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08830209.6 |
| Date of filing the European patent application | 2008-09-12 | |
| (97) | Date of publication of the European application | 2010-06-16 |
| (45) | Date of publication and mention of the grant of the patent | 2013-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/076147 |
| Date | 2008-09-12 |
| (87) | Number | WO 2009/036257 |
| Date | 2009-03-19 |
| (30) | Number | Date | Country code |
| 972196 P | 2007-09-13 | US |
| (72) |
LAVEDAN, Christian, US
POLYMEROPOULOS, Mihael H., US
BIRZNIEKS, Gunther, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
9605 Medical Center Drive, Suite 300, Rockville, MD 20850,
US
|
| (54) | PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE |
| PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE |